# ğŸ§ª Survival Analysis of Chlorhexidine Trial Outcomes  
**Kaplanâ€“Meier â€¢ Log-Rank â€¢ Cox PH â€¢ Schoenfeld Diagnostics**  
![MIT License](https://img.shields.io/badge/License-MIT-green.svg)

The complete article is included in the repository at:  
ğŸ“„ **[/document/Publication.pdf](document/Publication.pdf)**

This repository reproduces and interprets **time-to-VAP (Ventilator-Associated Pneumonia)** outcomes from a randomized clinical trial comparing **0.12% vs 0.20% chlorhexidine** mouthwash in ICU patients.

All results, tables, and plots are generated using the Python scripts in this repository.

---

# 2ï¸âƒ£ Project Summary
This project analyzes patient-level data from a randomized controlled trial comparing **0.12% vs 0.20% chlorhexidine** for preventing VAP in mechanically ventilated ICU patients.

### **Outcome**
- **time** â†’ number of days until VAP  
- **event** â†’ 1 = VAP occurred, 0 = censored (discharged, death, LAMA)

### **Why Survival Analysis?**
Patients had **different follow-up durations**, and many were **censored**, making classical statistics invalid.  
Thus, survival methods such as **Kaplanâ€“Meier**, **Log-Rank test**, **Cox model**, and **Schoenfeld checks** were used.

---

# 3ï¸âƒ£ Dataset Description  

### ğŸ“š Data Files
- `data/Chlorhexidine Trials.xlsx`  
- `data/Data form Chlorhexidine Trial (Raw).xlsx`

### ğŸ“˜ Core Variables

| Column        | Description                    | Type |
|---------------|--------------------------------|------|
| Age           | Age in years                   | Continuous |
| Gender        | Male / Female                  | Categorical |
| treatment_arm | 1 = 0.12%, 2 = 0.20%           | Categorical |
| apache_score  | APACHE II severity score       | Continuous |
| tlc_score     | Total leukocyte count          | Continuous |
| microbial_load| Microbial load (Day 1)         | Continuous |
| time          | Time to VAP / censoring        | Continuous |
| event         | 1 = VAP, 0 = No VAP            | Binary |

---

# 4ï¸âƒ£ Problem Statement  

This project answers key clinical questions:

- Does **chlorhexidine 0.20%** reduce the hazard of VAP compared to 0.12%?
- Is VAP-free survival different between the two treatment groups?
- Do baseline predictors (Age, APACHE II, TLC, Microbial load, Gender) affect time-to-VAP?
- Do survival curves differ significantly (Log-Rank test)?
- What do hazard ratios from the Cox model imply clinically?

---

# 5ï¸âƒ£ Objectives  

- Clean and preprocess the clinical dataset  
- Perform exploratory data analysis (EDA)  
- Estimate survival curves (overall + by treatment arm)  
- Compare groups using Log-Rank test  
- Fit Cox Proportional Hazards model  
- Check PH assumption using Schoenfeld residuals  
- Generate adjusted survival curves  
- Interpret survival estimates and hazard ratios clinically  

---

# 6ï¸âƒ£ Methodology  

### **6.1 Data Preparation**
- Import dataset  
- Handle missing values  
- Encode categorical variables  
- Rename variables where needed  
- Create survival objects: `duration = time`, `event = event`  

### **6.2 Exploratory Data Analysis**
- Distribution of events vs censored  
- Summary statistics  
- Histograms, boxplots  
- Correlation heatmap  
- Initial KM survival curves  

### **6.3 Survival Modelling**
â­ Kaplanâ€“Meier Estimator  
â­ Life Tables  
â­ Log-Rank Test  
â­ Cox Proportional Hazards Model  
â­ Checking PH assumptions (Schoenfeld residuals)  

### **6.4 Model Evaluation & Interpretation**
- Hazard ratios  
- P-values  
- 95% Confidence Intervals  
- Clinical significance interpretation  

---

# 7ï¸âƒ£ Python Implementation Structure  

```
â”œâ”€â”€ data/
â”‚ â”œâ”€â”€ Chlorhexidine Trials.xlsx
â”‚ â””â”€â”€ Data form Chlorhexidine Trial (Raw).xlsx
â”‚
â”œâ”€â”€ document/
â”‚ â”œâ”€â”€ Publication.pdf
â”‚ â””â”€â”€ interpretation_of_survival_analysis.docx
â”‚
â”œâ”€â”€ results/
â”‚ â”œâ”€â”€ adj_sc_micload.png
â”‚ â”œâ”€â”€ adj_sc_age.png
â”‚ â”œâ”€â”€ adj_sc_apachiscr.png
â”‚ â”œâ”€â”€ adj_sc_chestxray.png
â”‚ â”œâ”€â”€ adj_sc_culture.png
â”‚ â”œâ”€â”€ adj_sc_tlc_scr.png
â”‚ â”œâ”€â”€ correl_heatmap.png
â”‚ â”œâ”€â”€ cox_fit_ppl_hz.png
â”‚ â”œâ”€â”€ cox_forest_hr.png
â”‚ â”œâ”€â”€ cox_hr_table_final.csv
â”‚ â”œâ”€â”€ event_distribn.png
â”‚ â”œâ”€â”€ hazard_ratio_tbl.png
â”‚ â”œâ”€â”€ km_overall.png
â”‚ â”œâ”€â”€ km_trail_arm.png
â”‚ â”œâ”€â”€ logrank_two_arm_table.csv
â”‚ â”œâ”€â”€ lr_chi_table.png
â”‚ â”œâ”€â”€ nelson_aalen.png
â”‚ â”œâ”€â”€ ss_r_age.png
â”‚ â”œâ”€â”€ ss_r_apachscr.png
â”‚ â”œâ”€â”€ ss_r_chestxray.png
â”‚ â”œâ”€â”€ ss_r_culture.png
â”‚ â”œâ”€â”€ ss_r_mcr_load.png
â”‚ â””â”€â”€ ss_r_tlc_scr.png
â”‚
â”œâ”€â”€ Chlorhexidine_Survival_Analysis.ipynb
â”œâ”€â”€ LICENSE
â”œâ”€â”€ README.md
â””â”€â”€ requirements.txt
```

---

# 8ï¸âƒ£ Key Results & Visualizations  

### **ğŸ“Œ 1. Kaplanâ€“Meier (Overall Survival)**
![](results/km_overall.png)

### **ğŸ“Œ 2. KM by Treatment Arm**
![](results/km_trail_arm.png)

### **ğŸ“Œ 3. Log-Rank Test**
![](results/lr_chi_table.png)

### **ğŸ“Œ 4. Cox Model â€“ Forest Plot**
![](results/cox_forest_hr.png)

### **ğŸ“Œ 5. Schoenfeld Residual Diagnostics**
Examples:
![](results/ss_r_age.png)
![](results/ss_r_apachscr.png)
![](results/ss_r_chestxray.png)

### **ğŸ“Œ 6. Adjusted Survival Curves**
![](results/adj_sc_age.png)
![](results/adj_sc_apachiscr.png)
![](results/adj_sc_chestxray.png)

---

# ğŸ”Ÿ Discussion  

- Both chlorhexidine concentrations show **high VAP-free survival**.  
- Visual trend suggests 0.20% may perform slightly better, but **not statistically significant**.  
- Cox model results show **no strong predictors** due to small number of events.  
- PH assumption was **not violated** â†’ model is valid.  

---

# 1ï¸âƒ£1ï¸âƒ£ Conclusion  

- No significant difference between 0.12% and 0.20% chlorhexidine.  
- Cox model shows **no major hazard predictors** in this dataset.  
- Low event count limits statistical power.  
- Both concentrations are clinically comparable for VAP prevention.  

---

# 1ï¸âƒ£2ï¸âƒ£ Future Work  

- Larger sample size with more VAP events  
- Time-varying Cox models  
- Parametric survival models (Weibull, Exponential)  
- Machine learning survival techniques (RSF, DeepSurv)  
- Competing risks analysis (VAP vs mortality)  

---

# ğŸ“„ License  
This project is licensed under the **MIT License**.

---

<p align="center">
  <img src="https://img.shields.io/badge/Author-Vaishnavi%20K%20R%20%7C%20AI%20%26%20Data%20Science-blue?style=for-the-badge">
</p>
